Suppr超能文献

高密度脂蛋白缺乏症(丹吉尔病)患者血清补体活性升高:簇集素水平正常及其在动脉粥样硬化中的可能意义。

Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.

作者信息

Choi-Miura N H, Sakamoto T, Ohtaki S, Nakamura H, Ishizawa S, Takagi Y, Gomi K, Tomita M

机构信息

Department of Physiological Chemistry, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan.

出版信息

Clin Exp Immunol. 1993 Aug;93(2):242-7. doi: 10.1111/j.1365-2249.1993.tb07973.x.

Abstract

Clusterin (apolipoprotein J, SP-40,40), as well as apolipoprotein A-I (apo A-I) and apolipoprotein A-II (apo A-II), are apolipoprotein components of high density lipoprotein (HDL), but not of low density lipoprotein. In spite of the deficiencies of apo A-I, apo A-II and HDL in the sera of patients with Tangier disease, clusterin was found in them at normal level. While clusterin was present as the component of HDL with apo A-I in sera of normal donors, it was present as a protein which did not form a complex in sera of Tangier patients. SC5b-9 made from the sera of Tangier patients contained normal amounts of clusterin and was deficient in apo A-I, indicating that clusterin could be incorporated into the SC5b-9 complex without apo A-I. The complement activities of the sera of the patients were higher than those of normal donors. These results may be explained by the deficiencies of apo A-I, apo A-II and HDL in the patients, because they were suggested to be the inhibitors of the reactive haemolysis of complement. The elevated complement activities of the patients might be related to the severe atherosclerotic lesions in Tangier disease.

摘要

簇集蛋白(载脂蛋白J、SP - 40,40)以及载脂蛋白A - I(apo A - I)和载脂蛋白A - II(apo A - II)是高密度脂蛋白(HDL)的载脂蛋白成分,但不是低密度脂蛋白的成分。尽管丹吉尔病患者血清中的apo A - I、apo A - II和HDL存在缺陷,但仍发现其中的簇集蛋白水平正常。在正常供体血清中,簇集蛋白作为HDL与apo A - I的成分存在,而在丹吉尔病患者血清中,它以一种不形成复合物的蛋白质形式存在。由丹吉尔病患者血清制成的SC5b - 9含有正常量的簇集蛋白且缺乏apo A - I,这表明簇集蛋白可以在没有apo A - I的情况下被纳入SC5b - 9复合物。患者血清的补体活性高于正常供体。这些结果可能是由于患者体内apo A - I、apo A - II和HDL的缺陷所致,因为它们被认为是补体反应性溶血的抑制剂。患者补体活性升高可能与丹吉尔病中严重的动脉粥样硬化病变有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验